Showing results (81-90 of 100) with videos related to
Sort By:
Pageof 10
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 5, 2024
Dose/Exposure Relationship of Exercise and Distant Recurrence in Primary Breast CancerDavide Soldato, Stefan Michiels, Julie Havas, et al.Cancer|June 18, 2016
Randomized phase 2 neoadjuvant trial evaluating anastrozole and fulvestrant efficacy for postmenopausal, estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer patients: Results of the UNICANCER CARMINA 02 French trial (UCBG 0609)Florence Lerebours, Sofia Rivera, Marie-Ange Mouret-Reynier, et al.Breast Cancer Research and Treatment|October 26, 2018
Oral etoposide in heavily pre-treated metastatic breast cancer: results from the ESME cohort and comparison with other chemotherapy regimensLuc Cabel, Matthieu Carton, Bianca Cheaib, et al.Plos One|October 19, 2017
Prospective, multicenter French study evaluating the clinical impact of the Breast Cancer Intrinsic Subtype-Prosigna® Test in the management of early-stage breast cancersDelphine Hequet, Céline Callens, David Gentien, et al.JAMA Network Open|September 23, 2022
Contraceptive Use in Premenopausal Women With Early Breast CancerMatteo Lambertini, Claudia Massarotti, Julie Havas, et al.Breast (Edinburgh, Scotland)|February 9, 2021
Outcome beyond third-line chemotherapy for metastatic triple-negative breast cancer in the French ESME programLuc Cabel, Matthieu Carton, Barbara Pistilli, et al.British Journal of Cancer|February 1, 2020
Predictive factors of 5-year relapse-free survival in HR+/HER2- breast cancer patients treated with neoadjuvant endocrine therapy: pooled analysis of two phase 2 trialsFlorence Lerebours, Marina Pulido, Emmanuelle Fourme, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 3, 2020
Cognitive Impairment in Patients with Breast Cancer before Surgery: Results from a CANTO Cohort SubgroupMarie Lange, Isabelle Hardy-Léger, Idlir Licaj, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2025
HER2CLIMB-05: A Phase 3 Study of Tucatinib Versus Placebo in Combination with Trastuzumab and Pertuzumab as First-line Maintenance Therapy for HER2+ Metastatic Breast CancerVeronique Dieras, Giuseppe Curigliano, Miguel Martin, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2022
Long-Term Longitudinal Patterns of Patient-Reported Fatigue After Breast Cancer: A Group-Based Trajectory AnalysisInes Vaz-Luis, Antonio Di Meglio, Julie Havas, et al.Pageof 10